Chemo Graded Nitrile Powder-free Medical Examination Gloves Market Size, Share & Trends Analysis Report By Region (North America, Europe, Asia Pacific), And Segment Forecasts, 2023 - 2030

Report Overview

The global chemo graded nitrile powder-free medical examination gloves market size was valued at USD 274.7 million in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 10.5% from 2023 to 2030. Chemo-graded nitrile powder-free medical examination gloves are in high demand due to the rising cancer prevalence driving chemo demand globally. For instance, in 2021 there were 10.0 million fatalities and 19.3 million new cases of cancer worldwide. Furthermore, one in five people in the globe will get cancer at some point in their lives, and one in eight men and one in eleven women will die due to cancer in the coming years.

Growing awareness of cancer and the advantages of early diagnosis through screening services supported by several public and private organizations, market-based businesses, and hospitals through creative campaigns is likely to fuel market growth. For instance, the Oncolorelief project has developed an app that improves the well-being and health status of cancer patients after treatment, according to the European Health and Digital Executive Agency (HaDEA). Additionally, the Guardian Angel app makes use of data analytics to offer patients with acute myeloid leukemia and colorectal cancer individualized assistance in post-treatment activities.

A growing understanding of the different types of cancer and the factors that contribute to them is anticipated to aid in illness early detection and diagnosis. Patients are living longer owing to radiation, chemotherapy, and targeted medicine delivery. These aforementioned factors will drive the demand for chemo-graded nitrile powder-free medical examination gloves.

In 2022, there were 1.9 million new cancer cases identified and 609,360 cancer deaths in the U.S., according to the American Cancer Society. In addition, 609,360 Americans died due to cancer in 2022. The most common cause of death was lung and bronchus cancer, which claimed 130,180 lives in 2022.

When compared to colorectal cancer, which is the second leading cause of cancer deaths, is responsible for almost three times as many deaths. With 49,830 fatalities, pancreatic cancer is the third deadliest malignancy. Thus, it is anticipated that rising cancer rates in the U.S. will increase the demand for chemotherapy, propelling the market.

The U.S. Department of Health and Human Services estimated that the number of cancer survivors stood at 18.1 million in the U.S. as of January 2022. This is equivalent to about 5.4% of the total population. Furthermore, it is anticipated that by 2032, there would be 22.5 million more cancer survivors, an increase of 24.4%. The number of persons who have survived five or more years after receiving a cancer diagnosis is expected to rise by almost 30%, to 16.3 million, over the following ten years. These aforementioned factors will augment the demand for the chemo-graded nitrile powder-free medical examination gloves industry in the U.S. in the coming years.

In 2020, when COVID-19 cases soared in the U.S., oncologists, and health professionals, in general, were directed to caring for COVID-19 patients. As a result, there was a delay in cancer procedures, a decrease in chemotherapy dosages, and fewer in-person cancer treatment visits. To prevent cancer patients from being exposed to the coronavirus, doctors were encouraged to start telehealth appointments.

As a result, while the market demand declined in the U.S., the demand for disposable gloves required for COVID-19 treatment increased. The demand for chemo-graded nitrile powder-free medical examination gloves worldwide decreased further because of the utilization of cancer wards for the treatment of COVID-19 patients.

The healthcare sector in the U.S. is also anticipated to expand significantly as a result of several factors, including rising public and private sector investment, an expanding population, and a large influx of immigrants. Moreover, rising healthcare costs are likely to fuel the expansion of the U.S. healthcare sector, which is anticipated to increase demand for chemo-graded nitrile powder medical examination gloves over the forecast period.

Regional Insights

The Asia Pacific led the market and accounted for 42.5% of the global revenue share in 2022 due to the rapidly growing healthcare sector and strict rules designed to protect doctors and hospital staff. The usage of chemo-graded nitrile powder-free gloves is expanding as it shields medical staff from the negative effects of handling chemotherapy medications.

The penetration of nine distinct chemotherapy drugs has been tested and confirmed to survive chemotherapy gloves, which are protective gloves. While handling chemotherapy treatments, it is recommended to wear two pairs of gloves at once, even though these gloves are typically thicker than normal gloves. These aforementioned factors will drive market expansion in the coming years.

Demand for chemo-graded nitrile powder-free medical examination gloves is anticipated to increase over the forecast period as a result of government and NGO initiatives aimed at promoting research, raising awareness about cancer, increasing research funding, and implementing mass screening programs for cancer. One such organization is the Indian Cancer Society, which supports early cancer detection and cancer prevention by promoting cancer awareness and knowledge. However, the National Cancer Registry Program (NCRP) and other publicly accessible data sources indicate that the country's cancer burden is anticipated to rise to 29.8 million in 2025 and that it differs among India's regions, creating significant problems for its prevention and control.

The demand for chemo-graded nitrile powder-free medical examination is estimated to witness growth at a CAGR of 10.1% in the North America region over the forecast period. Early cancer identification with treatments like chemotherapy and radiation therapy is projected to increase healthcare spending, which will help the expansion of the North American market. For instance, chemotherapy will be necessary for 75% of the additional 5.2 million patients by 2040, and 67% of patients would need it. These aforementioned factors will drive market expansion in this region in the coming years.

To promote, implement, and develop effective cancer control and prevention practices that are expected to increase the demand for chemo-graded gloves in the U.S., the Centers for Disease Control and Prevention's (CDC) Cancer Prevention and Control section is working in cooperation with several territories, state health agencies, tribal organizations, and other government & non-government organizations.

In 2020, there were 4,39,843 new cases of cancer in Europe, according to the WHO. Moreover, more than one in four deaths in the U.K. was due to cancer. In the U.K., 1,67,142 people passed away from cancer in 2020. Thus, during the projection period, rising cancer-related fatalities and rising government initiatives for cancer treatment will fuel market demand.

Using steps to assist, coordinate, and supplement Member States' efforts, the European Beating Cancer Plan, for instance, seeks to lessen the burden of cancer and address cancer-related inequities between and within nations. These aforementioned factors will drive the market expansion in this region in the coming years

Key Companies & Market Share Insights

To get a competitive edge in the market, the market participants are concentrating on R&D activities and product launches to create better technologies for the production of chemo-graded nitrile powder-free medical examination gloves and amalgamation across various stages of the value chain.

For instance, Hartalega Holdings Berhad bought 250 acres of land from Northern Gateway Free Zone Sdn Bhd in March 2021, for USD 55.4 million to expand its manufacturing operations of gloves. Furthermore, in August 2020, Hartalega Holdings Berhad bought 60.57 acres piece of land in Selangor for USD 38.46 million to expand the production facility of gloves. Some prominent players in the global chemo graded nitrile powder-free medical examination gloves market include:

• Cardinal Health

• Top Glove Corporation Bhd

• Ansell Ltd.

• Kimberly-Clark Corporation

• Sempermed USA, Inc.

• Halyard Health, Inc.

• Tronex International, Inc.

• McKesson Medical-Surgical Inc.

• Hartalega Holdings Berhad

• Safeko

Chemo Graded Nitrile Powder-free Medical Examination Gloves Market Report Scope

Global Chemo Graded Nitrile Powder-free Medical Examination Gloves Market Report Segmentation

This report forecasts revenue growth at global, regional & country levels and provides an analysis of the latest industry trends from 2018 to 2030. For the purpose of this study, Grand View Research has segmented the global chemo graded nitrile powder-free medical examination gloves market report based on region:

• Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America

    • U.S.

    • Canada

  • Europe

    • Germany

    • U.K.

    • France

    • Russia

    • Italy

    • Spain

  • Asia Pacific

    • China

    • India

    • Japan

    • Australia

    • South Korea

    • Indonesia

  • Latin America

    • Brazil

    • Argentina

    • Mexico

  • Middle East & Africa

    • Saudi Arabia

    • UAE

    • South Africa